Tirzepatide , sold as Mounjaro for diabetes and Zepbound for weight management, is a dual GLP-1/GIP receptor agonist
Tirzepatide works on both GLP-1 and GIP receptors, helping regulate appetite, digestion, blood sugar levels, and satiety signals
In both trails, sample size, discontinuation rate, mean diabetes duration, and percentage of patients with established ASCVD were comparable
Prior to this episode, she had no reported neuropathy symptoms and exhibited full functional independence
This single alteration provides substantial resistance to enzymatic degradation, extending the peptide's utility in metabolic research
HSA and FSA funds cover all PlexusDx medications, and no membership fees or hidden charges apply